Far-Infrared Therapy

Lin, Chih Ching; Chang, Chin Sung; Lai, Ming Yu; Chen, Tzen Wen; Lee, Pui Ching; Wu, Yang Chang

doi:10.1681/asn.2006050534

Cited by 136 publications

(153 citation statements)

References 24 publications

(27 reference statements)

Supporting

Mentioning

144

Contrasting

Order By: Relevance

“…Chou et al [35,36] state that serum CRP levels not only predict cardiovascular disease and mortality in HD patients, but also predict the development of VA thrombosis (VAT), and that high pulse pressure (PP) was associated with the development of VAT in chronic HD patients. Far-infrared (FIR) therapy, a non-invasive and convenient therapeutic modality, can improve access blood flow (Qa) and survival of the AVF in HD patients through both its thermal and non-thermal effects [37] . Shuman et al [38] suggest that an organized clinical assessment, using a formal tracking tool, is equal to ultrasound flow measurements as a surveillance method to prevent HD access thrombosis.…”

Section: Permanent Vamentioning

confidence: 99%

Vascular access today

Pantelias

Grapsa²

2012

WJN

View full text Add to dashboard Cite

The number of patients with chronic kidney disease requiring renal replacement therapy has increased worldwide. The most common replacement therapy is hemodialysis (HD). Vascular access (VA) has a key role for successful treatment. Despite the advances that have taken place in the field of the HD procedure, few things have changed with regards to VA in recent years. Arteriovenous fistula (AVF), polytetrafluoroethylene graft and the cuffed double lumen silicone catheter are the most common used for VA. In the long term, a number of complications may present and more than one VA is needed during the HD life. The most common complications for all of VA types are thrombosis, bleeding and infection, the most common cause of morbidity in these patients. It has been estimated that VA dysfunction is responsible for 20% of all hospitalizations. The annual cost of placing and looking after dialysis VA in the United States exceeds 1 billion dollars per year. A good functional access is also vital in order to deliver adequate HD therapy. It seems that the native AVF that Brescia and Cimino described in 1966 still remains the first choice for VA. The native forearm AVFs have the longest survival and require the fewest interventions. For this reason, the forearm AVF is the first choice, followed by the upper-arm AVF, the arteriovenous graft and the cuffed central venous catheter is the final choice. In conclusion, VA remains the most important issue for patients on HD and despite the technical improvements, a number of problems and complications have to be resolved.

show abstract

Section: Permanent Vamentioning

confidence: 99%

Vascular access today

Pantelias

Grapsa²

2012

WJN

View full text Add to dashboard Cite

show abstract

“…FIR therapy is often used as alternative physical therapy to decrease joint stiffness, relieve muscle spasms, assist soft tissue injury repair, lead to pain relief, and help to resolve inflammatory infiltrated edema. FIR therapy can improve blood flow and survival of the arteriovenous fistula in hemodialysis patients (Lin, et al, 2007). Furthermore, FIR stimulation on acupoints at Qihai, Kuan yuan and Chung chi decreases both stress and fatigue levels as well as stimulates autonomic nervous system activity in hemodialysis patients (Su, et al, 2009).…”

Section: Photobiologymentioning

confidence: 99%

Phototherapy for the Treatment of Allergic Rhinitis

Hu¹,

Li²

2012

Allergic Rhinitis

View full text Add to dashboard Cite

“…The rationale for far infrared therapy to treat dialysis vascular access stenosis is that the dialysis vascular access in patients are located at a superficial site and improving access flow may improve vascular access performance. In the lone clinical study of far infrared in dialysis access in AVFs, patients who received far infrared therapy had improved access flows and longer unassisted patencies 190 .…”

Section: Far Infrared Therapymentioning

confidence: 99%

Hemodialysis Vascular Access Dysfunction

Lee¹

2011

Progress in Hemodialysis - From Emergent Biotechnology to Clinical Practice

View full text Add to dashboard Cite

Far-Infrared Therapy

Cited by 136 publications

References 24 publications

Vascular access today

Vascular access today

Phototherapy for the Treatment of Allergic Rhinitis

Hemodialysis Vascular Access Dysfunction

Contact Info

Product

Resources

About